Literature DB >> 7439982

Cytotoxic lymphocytes and antibody-dependent complement-mediated cytotoxicity induced by administration of influenza vaccine.

G V Quinnan, F A Ennis, C U Tuazon, M A Wells, G M Butchko, R Armstrong, C McLaren, J F Manischewitz, S Kiley.   

Abstract

Recently defined aspects of cellular and humoral antiviral immunity were evaluated in 10 young adults given influenza vaccines containing A/USSR/77 (H1N1) antigens. Cytotoxic lymphocytes were measured by using cryopreserved lymphocytes as effector cells and syngeneic, virus-infected lymphocytes as target cells. An assay previously developed in this laboratory was adapted for the measurement of antibody-dependent, complement-mediated cytotoxicity. Antiviral cytotoxic lymphocyte responses were detected in 5 of 10 volunteers between 3 and 10 days after the initial vaccination. These responses were found both in individuals who were previously primed and in individuals who were not primed to influenza A/USSR/77 antigens. The complement-mediated lysis assay was found to be more sensitive than the hemagglutination inhibition test and probably detected antibodies to both subtype-specific and cross-reactive antigenic determinants. These responses to influenza antigens are similar to those obtained in studies of murine influenza which indicate that cytotoxic lymphocytes and antibody-dependent, complement-mediated cytotoxicity have a role in the early response to acute infection.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7439982      PMCID: PMC551319          DOI: 10.1128/iai.30.2.362-369.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Cytotoxic T lymphocyte response to murine cytomegalovirus infection.

Authors:  G V Quinnan; J E Manischewitz; F A Ennis
Journal:  Nature       Date:  1978-06-15       Impact factor: 49.962

2.  Influenza A viruses of the H2N2 subtype are lymphocyte mitogens.

Authors:  G M Butchko; R B Armstrong; W J Martin; F A Ennis
Journal:  Nature       Date:  1978-01-05       Impact factor: 49.962

3.  Cytotoxic T lymphocytes induced in mice by inactivated influenza virus vaccine.

Authors:  F A Ennis; W J Martin; M W Verbonitz
Journal:  Nature       Date:  1977-09-29       Impact factor: 49.962

4.  Lymphocyte-mediated cytotoxicity to cells infected with measles virus. I. Use of in vitro infected leukocytes as autologous target cells; absence of virus-specific cytotoxic lymphocytes.

Authors:  J M Galama; C J Lucas; A Vos
Journal:  Cell Immunol       Date:  1978-07       Impact factor: 4.868

5.  HLA restriction of cell-mediated lysis of influenza virus-infected human cells.

Authors:  A J McMichael; A Ting; H J Zweerink; B A Askonas
Journal:  Nature       Date:  1977-12-08       Impact factor: 49.962

6.  Lymphocyte blastogenic responses to influenza virus antigens after influenza infection and vaccination in humans.

Authors:  R Dolin; B R Murphy; E A Caplan
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

7.  Lymphocyte cytotoxicity to influenza virus-infected cells: response to vaccination and virus infection.

Authors:  S B Greenberg; B S Criswell; H R Six; R B Couch
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

8.  Specificity studies on cytotoxic thymus-derived lymphocytes reactive with influenza virus-infected cells: evidence for dual recognition of H-2 and viral hemagglutinin antigens.

Authors:  F A Ennis; W J Martin; M W Verbonitz; G M Butchko
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

9.  Hemagglutinin-specific complement-dependent cytolytic antibody response to influenza infection.

Authors:  M W Verbonitz; F A Ennis; J T Hicks; P Albrecht
Journal:  J Exp Med       Date:  1978-01-01       Impact factor: 14.307

10.  Hemagglutinin-specific cytotoxic T-cell response during influenza infection.

Authors:  F A Ennis; W J Martin; M W Verbonitz
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

View more
  14 in total

1.  Safety and immunogenicity of multimeric-001--a novel universal influenza vaccine.

Authors:  Jacob Atsmon; Efrat Kate-Ilovitz; Dimitry Shaikevich; Yossi Singer; Inna Volokhov; Kirsten Y Haim; Tamar Ben-Yedidia
Journal:  J Clin Immunol       Date:  2012-02-09       Impact factor: 8.317

2.  Comparison of complement dependent lytic, hemagglutination inhibition and microneutralization antibody responses in influenza vaccinated individuals.

Authors:  Mary Dawn T Co; John Cruz; Akira Takeda; Francis A Ennis; Masanori Terajima
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

3.  Relationship of preexisting influenza hemagglutination inhibition, complement-dependent lytic, and antibody-dependent cellular cytotoxicity antibodies to the development of clinical illness in a prospective study of A(H1N1)pdm09 Influenza in children.

Authors:  Mary Dawn T Co; Masanori Terajima; Stephen J Thomas; Richard G Jarman; Kamonthip Rungrojcharoenkit; Stefan Fernandez; In-Kyu Yoon; Darunee Buddhari; John Cruz; Francis A Ennis
Journal:  Viral Immunol       Date:  2014-08-20       Impact factor: 2.257

4.  Declining responsiveness to influenza vaccination with progression of human pregnancy.

Authors:  Elizabeth P Schlaudecker; Lilliam Ambroggio; Monica M McNeal; Fred D Finkelman; Sing Sing Way
Journal:  Vaccine       Date:  2018-06-22       Impact factor: 3.641

Review 5.  Fc or not Fc; that is the question: Antibody Fc-receptor interactions are key to universal influenza vaccine design.

Authors:  Sinthujan Jegaskanda; Hillary A Vanderven; Adam K Wheatley; Stephen J Kent
Journal:  Hum Vaccin Immunother       Date:  2017-03-23       Impact factor: 3.452

6.  Induction of H7N9-Cross-Reactive Antibody-Dependent Cellular Cytotoxicity Antibodies by Human Seasonal Influenza A Viruses that are Directed Toward the Nucleoprotein.

Authors:  Sinthujan Jegaskanda; Mary Dawn T Co; John Cruz; Kanta Subbarao; Francis A Ennis; Masanori Terajima
Journal:  J Infect Dis       Date:  2017-03-01       Impact factor: 5.226

7.  Passive immunization with influenza haemagglutinin specific monoclonal antibodies.

Authors:  Rajeev Rudraraju; Kanta Subbarao
Journal:  Hum Vaccin Immunother       Date:  2018-07-16       Impact factor: 3.452

8.  High Antibody-Dependent Cellular Cytotoxicity Antibody Titers to H5N1 and H7N9 Avian Influenza A Viruses in Healthy US Adults and Older Children.

Authors:  Masanori Terajima; Mary Dawn T Co; John Cruz; Francis A Ennis
Journal:  J Infect Dis       Date:  2015-03-20       Impact factor: 5.226

9.  Complement-dependent lysis of influenza a virus-infected cells by broadly cross-reactive human monoclonal antibodies.

Authors:  Masanori Terajima; John Cruz; Mary Dawn T Co; Jane-Hwei Lee; Kaval Kaur; Jens Wrammert; Patrick C Wilson; Francis A Ennis
Journal:  J Virol       Date:  2011-10-12       Impact factor: 5.103

10.  Influence of prior cellular immunity on the in vitro lymphocyte response to virus antigens after influenza vaccination.

Authors:  W A Briggs
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.